NRX Pharmaceuticals (NRXP) Q2 2026 Earnings

15MayConfirmed
Q2 2025
Q2 2025
Q4 2025
Q2 2026
-0.98
-0.58
-0.19
0.21

Details

Expected EPS
0.20896
Actual EPS
-0.04
Surprise EPS
-0.25
Surprise Percent
+119.14%

Description

NRX Pharmaceuticals (NRXP) has reported earnings of -0.04 per share for Q2 2026.

0 Comments

Share your thoughts